Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Detrusor Overactivity”

117 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 117 results

Large-scale testing (Phase 3)Study completedNCT02501928
What this trial is testing

Open-label Long-term Extension Study of Fesoterodine in Japanese Subjects With Neurogenic Detrusor Overactivity.

Who this might be right for
Urinary Bladder, Neurogenic
Pfizer 12
Testing effectiveness (Phase 2)Study completedNCT01657409
What this trial is testing

Different Injection Number of the Same Dose of Botulinum Toxin A on Overactive Bladder Syndrome

Who this might be right for
Overactive Bladder
Buddhist Tzu Chi General Hospital 90
Testing effectiveness (Phase 2)Ended earlyNCT00712322
What this trial is testing

A Two-week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Years) With Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Detrusor Overactivity
Warner Chilcott 35
Not applicableStudy completedNCT01629433
What this trial is testing

Onabotulinumtoxina Intradetrusorial Injections and NGF Expression

Who this might be right for
Overactive DetrusorDetrusor Hyperreflexia of Bladder
University Of Perugia 25
Not applicableStudy completedNCT02072928
What this trial is testing

Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence From Neurogenic Detrusor Overactivity in Belgium

Who this might be right for
Urinary Incontinence
Allergan 55
Post-approval studies (Phase 4)UnknownNCT00822913
What this trial is testing

Botulinum A Toxin in Patients With Parkinson's Disease

Who this might be right for
Parkinson's DiseaseMultiple System AtrophyDetrusor Overactivity
University Of Perugia 20
Post-approval studies (Phase 4)Study completedNCT04270526
What this trial is testing

Minimizing Pain During Office Intradetrussor Botox Injection

Who this might be right for
Overactive BladderOveractive DetrusorOveractive Bladder Syndrome+2 more
Boston Urogynecology Associates 85
Post-approval studies (Phase 4)Study completedNCT01661166
What this trial is testing

Effects of Fesoterodine in Men at High Risk for Overactive Bladder/Detrusor Overactivity Post Robotic-Assisted Lap. Prostatectomy

Who this might be right for
Prostate Adenocarcinoma
Abramson Cancer Center at Penn Medicine 3
Not applicableUnknownNCT04693897
What this trial is testing

Effect of beta3-adrenoceptor Agonist on Patients With Overactive Bladder and as a Urinary Biomarker

Who this might be right for
Overactive Bladder SyndromeDetrusor Overactivity
Chang Gung Memorial Hospital 400
Not applicableStudy completedNCT04981054
What this trial is testing

BO and DO in Women With Cystocele Before and After Cystocele Repair

Who this might be right for
Bladder OversensitivityDetrusor, Overactive
National Taiwan University Hospital 483
Not applicableStudy completedNCT04543552
What this trial is testing

A Comparative Analysis of Portable Bladder Scanner to Determine Age/ Volume Specific Accuracy in 0-6 Years of Children

Who this might be right for
Neurogenic BladderDetrusor UnderactivityDetrusor Overactivity
Seoul National University Hospital 34
Early research (Phase 1)Study completedNCT04452838
What this trial is testing

Study To Assess The Bioequivalence Under Fed And Fasted Conditions Of The Fesoterodine Beads-In-Capsule SR4 And SR7 Formulations And To Estimate The Bioavailability of SR7 Beads Sprinkled On Apple Sauce Relative To The Beads-In-Capsule SR7 Formulation Administer

Who this might be right for
Neurogenic Detrusor Overactivity
Pfizer 37
Testing effectiveness (Phase 2)Study completedNCT00857896
What this trial is testing

Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years

Who this might be right for
Overactive BladderNeurogenic Detrusor Overactivity
Pfizer 21
Not applicableStudy completedNCT02670486
What this trial is testing

Audiovisual Stimulus During Urodynamics

Who this might be right for
Overactive Bladder
Women and Infants Hospital of Rhode Island 218
Large-scale testing (Phase 3)Study completedNCT02849418
What this trial is testing

Efficacy and Safety Study of GSK1358820 in Japanese Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity

Who this might be right for
Urinary Bladder, Overactive
GlaxoSmithKline 21
Large-scale testing (Phase 3)Ended earlyNCT02660359
What this trial is testing

Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2

Who this might be right for
Urinary IncontinenceOveractive Bladder
Ipsen 258
Not applicableStudy completedNCT05504200
What this trial is testing

Transcutaneous Spinal Cord Stimulation With Bladder and Pelvic Floor Muscle Training

Who this might be right for
Spinal Cord Injuries
RNOH RIC 15
Not applicableStudy completedNCT01297660
What this trial is testing

Neuro-urological Outcome After Spinal Cord Injury

Who this might be right for
Urinary Bladder Neurogenic Dysfunction
Balgrist University Hospital 55
Post-approval studies (Phase 4)Looking for participantsNCT06479720
What this trial is testing

Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder

Who this might be right for
Effect of DrugUrinary Bladder, Overactive
Mackay Memorial Hospital 300
Early research (Phase 1)Study completedNCT02526979
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)

Who this might be right for
Overactive BladderNeurogenic Detrusor Overactivity
Astellas Pharma Europe B.V. 9
Load More Results